Back
Poseida Therapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
45
PSTX
Poseida Therapeutics
Last Price:
2.75
Seasonality Move:
20.58%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTX is experiencing selling pressure, which indicates risk of future bearish movement.
Poseida Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.18 | Sell |
| 20-day SMA: | 2.75 | Buy |
| 50-day SMA: | 2.81 | Sell |
| 200-day SMA: | 2.98 | Sell |
| 8-day EMA: | 3.08 | Sell |
| 20-day EMA: | 2.89 | Sell |
| 50-day EMA: | 2.83 | Sell |
| 200-day EMA: | 2.91 | Sell |
Poseida Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 47.72 | Sell |
| Chaikin Money Flow: | -623533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.33 - 3.09) | Buy |
| Bollinger Bands (100): | (2.58 - 3.32) | Sell |
Poseida Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Poseida Therapeutics Stock
Is Poseida Therapeutics Stock a Buy?
- Poseida Therapeutics share price is 2.76 while PSTX 8-day simple moving average is 3.18, which is a Sell signal.
- The stock price of PSTX is 2.76 while Poseida Therapeutics 20-day SMA is 2.75, which makes it a Buy.
- Poseida Therapeutics 50-day simple moving average is 2.81 while PSTX share price is 2.76, making it a Sell technically.
- PSTX stock price is 2.76 and Poseida Therapeutics 200-day simple moving average is 2.98, creating a Sell signal.
PSTX Technical Analysis vs Fundamental Analysis
Sell
45
Poseida Therapeutics (PSTX)
is a Sell
Is Poseida Therapeutics a Buy or a Sell?
-
Poseida Therapeutics stock is rated a Sell
The current Poseida Therapeutics [PSTX] share price is $2.76. The Score for PSTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Poseida Therapeutics Stock Info
Market Cap:
269M
Price in USD:
2.76
Share Volume:
699.88K
Poseida Therapeutics 52-Week Range
52-Week High:
4.27
52-Week Low:
1.87
Sell
45
Poseida Therapeutics (PSTX)
is a Sell
Poseida Therapeutics Share Price Forecast
-
What is the Poseida Therapeutics stock price today?
The Poseida Therapeutics stock price is 2.76 USD today. -
Will PSTX stock go up or go down?
Poseida Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Poseida Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Poseida Therapeutics is overvalued.
Is Poseida Therapeutics Stock a Buy?
- Poseida Therapeutics share price is 2.76 while PSTX 8-day exponential moving average is 3.08, which is a Sell signal.
- The stock price of PSTX is 2.76 while Poseida Therapeutics 20-day EMA is 2.89, which makes it a Sell.
- Poseida Therapeutics 50-day exponential moving average is 2.83 while PSTX share price is 2.76, making it a Sell technically.
- PSTX stock price is 2.76 and Poseida Therapeutics 200-day simple moving average is 2.91, creating a Sell signal.
Fundamental Analysis of Poseida Therapeutics
Is Poseida Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $1.08 per share.
Technical Analysis of Poseida Therapeutics
Should I short Poseida Therapeutics stock?
- PSTX Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Poseida Therapeutics is a Buy
- Poseida Therapeutics Relative Strength Index (RSI) is 47.72, which suggest Poseida Therapeutics is oversold
- The Bollinger Bands (25) for Poseida Therapeutics is (2.33 - 3.09), which suggest Poseida Therapeutics is a Sell
- The Bollinger Bands (100) for Poseida Therapeutics is (2.58 - 3.32), which suggest Poseida Therapeutics is a Sell
* Poseida Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.